Sequential loss of myelin proteins during Wallerian degeneration in the rat spinal cord

Axotomy of nerve fibers leads to the subsequent degeneration of their distal part, a process termed Wallerian degeneration (WD). While WD in the peripheral nervous system is usually followed by regeneration of the lesioned axons, central nervous system (CNS) neurons are generally unable to regrow. In this study, we investigated the process of WD in the dorsal columns of the rat spinal cord rostral to a mid‐thoracic lesion. We confirm earlier studies describing a very delayed microglial and an early and sustained astroglial reaction finally leading to scar formation. Interestingly, we found a differential time course in the loss of myelin proteins depending on their location. Proteins situated on the periaxonal myelin membrane such as myelin associated glycoprotein disappeared early, within a few days after lesion, concomitantly with cytoskeletal axonal proteins, whereas compact myelin and outer myelin membrane proteins such as MBP and Nogo‐A remained for long intervals in the degenerating tracts. Two distinct mechanisms are probably responsible for this difference: processes of protein destruction emanating from and initially probably located in the axon act on a time scale of 1–3 days. In contrast, the bulk of myelin destruction is due to phagocytosis known to be slow, prolonged, and inefficient in the CNS. These results may also have implications for future intervention strategies aiming at enhancing CNS regeneration. GLIA 42:424–432, 2003. © 2003 Wiley‐Liss, Inc.

[1]  Zhigang He,et al.  Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth , 2002, Nature.

[2]  A. Fournier,et al.  Myelin-Associated Glycoprotein as a Functional Ligand for the Nogo-66 Receptor , 2002, Science.

[3]  Zhigang He,et al.  Involvement of the Ubiquitin-Proteasome System in the Early Stages of Wallerian Degeneration , 2003, Neuron.

[4]  M. Schwab,et al.  Secondary Cell Death and the Inflammatory Reaction After Dorsal Hemisection of the Rat Spinal Cord , 1994, The European journal of neuroscience.

[5]  M. Webb,et al.  A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody , 1984, Journal of Neuroimmunology.

[6]  J W Griffin,et al.  Macrophage function during Wallerian degeneration of rat optic nerve: clearance of degenerating myelin and Ia expression , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[7]  M. Schwab Nogo and axon regeneration , 2004, Current Opinion in Neurobiology.

[8]  Martin E. Schwab,et al.  Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1 , 2000, Nature.

[9]  M. Schwab,et al.  Systemic Deletion of the Myelin-Associated Outgrowth Inhibitor Nogo-A Improves Regenerative and Plastic Responses after Spinal Cord Injury , 2003, Neuron.

[10]  M. Svensson,et al.  Glial cell responses, complement, and clusterin in the central nervous system following dorsal root transection , 1998, Glia.

[11]  M. Kliot,et al.  Differential Macrophage Responses in the Peripheral and Central Nervous System during Wallerian Degeneration of Axons , 1995, Experimental Neurology.

[12]  B. Scheithauer,et al.  A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. , 1999, Brain : a journal of neurology.

[13]  M. Filbin,et al.  Soluble Myelin-Associated Glycoprotein Released from Damaged White Matter Inhibits Axonal Regeneration , 2001, Molecular and Cellular Neuroscience.

[14]  L. Ronnevi,et al.  Myelin breakdown and elimination in the posterior funiculus of the adult cat after dorsal rhizotomy: A light and electron microscopic qualitative and quantitative study , 1984, The Journal of comparative neurology.

[15]  J. Bresnahan,et al.  Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys , 1997, Nature Medicine.

[16]  W. Schlaepfer Calcium-induced degeneration of axoplasm in isolated segments of rat peripheral nerve. , 1974, Brain research.

[17]  M. Schwab,et al.  Degeneration and regeneration of axons in the lesioned spinal cord. , 1996, Physiological reviews.

[18]  L. Noble,et al.  Vascular events after spinal cord injury: contribution to secondary pathogenesis. , 2000, Physical therapy.

[19]  H. Aldskogius,et al.  Central neuron–glial and glial–glial interactions following axon injury , 1998, Progress in Neurobiology.

[20]  S. Waxman,et al.  Non-synaptic mechanisms of Ca2+-mediated injury in CNS white matter , 1991, Trends in Neurosciences.

[21]  S. McLoon Response of astrocytes in the visual system to Wallerian degeneration: An immunohistochemical analysis of laminin and glial fibrillary acidic protein (GFAP) , 1986, Experimental Neurology.

[22]  W. Brück The Role of Macrophages in Wallerian Degeneration , 1997, Brain pathology.

[23]  M. Murray,et al.  Modification of astrocytes in the spinal cord following dorsal root or peripheral nerve lesions , 1990, Experimental Neurology.

[24]  S. Jander,et al.  The role of microglia and macrophages in the pathophysiology of the CNS , 1999, Progress in Neurobiology.

[25]  E. Kozlova,et al.  Effects of Dorsal Root Transection on Morphology and Chemical Composition of Degenerating Nerve Fibers and Reactive Astrocytes in the Dorsal Funiculus , 2000, Experimental Neurology.

[26]  M. Beattie,et al.  Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats , 1997, Journal of neuroscience research.

[27]  J. Noth,et al.  Gradual loss of myelin and formation of an astrocytic scar during Wallerian degeneration in the human spinal cord. , 2004, Brain : a journal of neurology.

[28]  M. Filbin,et al.  A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration , 1994, Neuron.

[29]  A. Amar,et al.  Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. , 1999, Neurosurgery.

[30]  L. Lubińska Early course of wallerian degeneration in myelinated fibres of the rat phrenic nerve , 1977, Brain Research.

[31]  R. Quencer,et al.  MR-pathologic comparisons of wallerian degeneration in spinal cord injury. , 1995, AJNR. American journal of neuroradiology.

[32]  J. Li,et al.  Cell surface morphology identifies microglia as a distinct class of mononuclear phagocyte , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[33]  J. Miklossy,et al.  The Long-Distance Effects of Brain Lesions: Visualization of Myelinated Pathways in the Human Brain Using Polarizing and Fluorescence Microscopy , 1991, Journal of neuropathology and experimental neurology.

[34]  J W Griffin,et al.  Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[35]  A. B. Huber,et al.  Nogo-A Inhibits Neurite Outgrowth and Cell Spreading with Three Discrete Regions , 2003, The Journal of Neuroscience.

[36]  A. Waller XX. Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibres , 1850, Philosophical Transactions of the Royal Society of London.

[37]  Guido Stoll,et al.  Nerve Injury, Axonal Degeneration and Neural Regeneration: Basic Insights , 1999, Brain pathology.

[38]  Noth,et al.  Dynamics of microglial activation in the spinal cord after cerebral infarction are revealed by expression of MHC class II antigen , 1998, Neuropathology and applied neurobiology.

[39]  J. Griffin,et al.  Delayed Macrophage Responses and Myelin Clearance during Wallerian Degeneration in the Central Nervous System: The Dorsal Radiculotomy Model , 1994, Experimental Neurology.

[40]  M. Schachner,et al.  Lack of evidence that myelin-associated glycoprotein is a major inhibitor of axonal regeneration in the CNS , 1995, Neuron.

[41]  S. B. Kater,et al.  Myelin‐associated glycoprotein inhibits neurite/axon growth and causes growth cone collapse , 1996, Journal of neuroscience research.

[42]  Jonathan D. Glass,et al.  Macrophage responses and myelin clearance during Wallerian degeneration: relevance to immune-mediated demyelination , 1992, Journal of Neuroimmunology.

[43]  J. Noth,et al.  Sequential loss of myelin proteins during Wallerian degeneration in the human spinal cord. , 2004, Brain : a journal of neurology.

[44]  V. Perry,et al.  Quantification of the mononuclear phagocyte response to Wallerian degeneration of the optic nerve , 1994, Journal of neurocytology.

[45]  V. Perry,et al.  Axon pathology in neurological disease: a neglected therapeutic target , 2002, Trends in Neurosciences.

[46]  R. Huber,et al.  Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Griffin,et al.  The proximo-distal spread of axonal degeneration in the dorsal columns of the rat , 1994, Journal of neurocytology.

[48]  J. Kim,et al.  ProNGF Induces p75-Mediated Death of Oligodendrocytes following Spinal Cord Injury , 2002, Neuron.

[49]  J. Noth,et al.  Expression pattern of NOGO-A protein in the human nervous system , 2005, Acta Neuropathologica.

[50]  J. Gabriel,et al.  Confocal microscopic localization of anti-myelin-associated glycoprotein autoantibodies in a patient with peripheral neuropathy initially lacking a detectable IgM gammopathy , 1998, Acta Neuropathologica.

[51]  S. Rotshenker,et al.  The Cytokine Network of Wallerian Degeneration: Tumor Necrosis Factor-α, Interleukin-1α, and Interleukin-1β , 2002, The Journal of Neuroscience.

[52]  A. Srinivasan,et al.  Apoptosis after traumatic human spinal cord injury. , 1998, Journal of neurosurgery.

[53]  S. Rotshenker,et al.  The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.